Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Preiss

Showing results (101-110 of 160) with videos related to

Pageof 16
Sort By:
Circulation|March 7, 2022
Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular DiseaseCiaran N Kohli-Lynch, James Lewsey, Kathleen A Boyd, et al.
JACC. Heart Failure|August 8, 2015
Falling Cardiovascular Mortality in Heart Failure With Reduced Ejection Fraction and Implications for Clinical TrialsChristopher J Rush, Ross T Campbell, Pardeep S Jhund, et al.
Respiratory Medicine|August 15, 2009
A simple and portable breathing circuit designed for ventilatory muscle endurance training (VMET)Dahlia Y Balaban, Rosemary Regan, Alexandra Mardimae, et al.
Hypertension (Dallas, Tex. : 1979)|December 16, 2015
Prediction of Cardiovascular Disease Risk by Cardiac Biomarkers in 2 United Kingdom Cohort Studies: Does Utility Depend on Risk Thresholds For Treatment?Paul Welsh, Carole Hart, Olia Papacosta, et al.
The Lancet. Diabetes & Endocrinology|August 19, 2019
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trialsSøren L Kristensen, Rasmus Rørth, Pardeep S Jhund, et al.
Soft Robotics|February 2, 2023
Modular Morphing Lattices for Large-Scale Underwater Continuum Robotic StructuresAlfonso Parra Rubio, Dixia Fan, Benjamin Jenett, et al.
The American Journal of Cardiology|December 10, 2017
Effect of Evolocumab on Lipoprotein ParticlesPeter P Toth, Naveed Sattar, Dirk J Blom, et al.
Respiratory Physiology & Neurobiology|January 15, 2013
The in-vivo oxyhaemoglobin dissociation curve at sea level and high altitudeDahlia Y Balaban, James Duffin, David Preiss, et al.
Circulation|March 3, 2017
Pooled Safety Analysis of Evolocumab in Over 6000 Patients From Double-Blind and Open-Label Extension StudiesPeter P Toth, Olivier Descamps, Jacques Genest, et al.
The Journal of Clinical Endocrinology and Metabolism|December 18, 2015
Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective StudiesA Katrina Loomis, Shaum Kabadi, David Preiss, et al.
Pageof 16

Showing results (101-110 of 160) with videos related to

Sort By:
Pageof 16
Circulation|March 7, 2022
Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular DiseaseCiaran N Kohli-Lynch, James Lewsey, Kathleen A Boyd, et al.
JACC. Heart Failure|August 8, 2015
Falling Cardiovascular Mortality in Heart Failure With Reduced Ejection Fraction and Implications for Clinical TrialsChristopher J Rush, Ross T Campbell, Pardeep S Jhund, et al.
Respiratory Medicine|August 15, 2009
A simple and portable breathing circuit designed for ventilatory muscle endurance training (VMET)Dahlia Y Balaban, Rosemary Regan, Alexandra Mardimae, et al.
Hypertension (Dallas, Tex. : 1979)|December 16, 2015
Prediction of Cardiovascular Disease Risk by Cardiac Biomarkers in 2 United Kingdom Cohort Studies: Does Utility Depend on Risk Thresholds For Treatment?Paul Welsh, Carole Hart, Olia Papacosta, et al.
The Lancet. Diabetes & Endocrinology|August 19, 2019
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trialsSøren L Kristensen, Rasmus Rørth, Pardeep S Jhund, et al.
Soft Robotics|February 2, 2023
Modular Morphing Lattices for Large-Scale Underwater Continuum Robotic StructuresAlfonso Parra Rubio, Dixia Fan, Benjamin Jenett, et al.
The American Journal of Cardiology|December 10, 2017
Effect of Evolocumab on Lipoprotein ParticlesPeter P Toth, Naveed Sattar, Dirk J Blom, et al.
Respiratory Physiology & Neurobiology|January 15, 2013
The in-vivo oxyhaemoglobin dissociation curve at sea level and high altitudeDahlia Y Balaban, James Duffin, David Preiss, et al.
Circulation|March 3, 2017
Pooled Safety Analysis of Evolocumab in Over 6000 Patients From Double-Blind and Open-Label Extension StudiesPeter P Toth, Olivier Descamps, Jacques Genest, et al.
The Journal of Clinical Endocrinology and Metabolism|December 18, 2015
Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective StudiesA Katrina Loomis, Shaum Kabadi, David Preiss, et al.
Pageof 16